These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33293576)

  • 1. Mild hyperlipidemia in mice aggravates platelet responsiveness in thrombus formation and exploration of platelet proteome and lipidome.
    van Geffen JP; Swieringa F; van Kuijk K; Tullemans BME; Solari FA; Peng B; Clemetson KJ; Farndale RW; Dubois LJ; Sickmann A; Zahedi RP; Ahrends R; Biessen EAL; Sluimer JC; Heemskerk JWM; Kuijpers MJE
    Sci Rep; 2020 Dec; 10(1):21407. PubMed ID: 33293576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice.
    Karshovska E; Zhao Z; Blanchet X; Schmitt MM; Bidzhekov K; Soehnlein O; von Hundelshausen P; Mattheij NJ; Cosemans JM; Megens RT; Koeppel TA; Schober A; Hackeng TM; Weber C; Koenen RR
    Circ Res; 2015 Feb; 116(4):587-99. PubMed ID: 25472975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a single bout of strenuous exercise on platelet activation in female ApoE/LDLR
    Przyborowski K; Kassassir H; Wojewoda M; Kmiecik K; Sitek B; Siewiera K; Zakrzewska A; Rudolf AM; Kostogrys R; Watala C; Zoladz JA; Chlopicki S
    Platelets; 2017 Nov; 28(7):657-667. PubMed ID: 28067100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR2 Plays a Key Role in Platelet Hyperreactivity and Accelerated Thrombosis Associated With Hyperlipidemia.
    Biswas S; Zimman A; Gao D; Byzova TV; Podrez EA
    Circ Res; 2017 Sep; 121(8):951-962. PubMed ID: 28775078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperlipidemia promotes thrombosis after injury to atherosclerotic vessels in apolipoprotein E-deficient mice.
    Eitzman DT; Westrick RJ; Xu Z; Tyson J; Ginsburg D
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1831-4. PubMed ID: 10894825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of hyperlipidemic rabbit models using multiple sgRNAs targeted CRISPR/Cas9 gene editing system.
    Yuan T; Zhong Y; Wang Y; Zhang T; Lu R; Zhou M; Lu Y; Yan K; Chen Y; Hu Z; Liang J; Fan J; Cheng Y
    Lipids Health Dis; 2019 Mar; 18(1):69. PubMed ID: 30885208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counteract of bone marrow of blotchy mice against the increases of plasma copper levels induced by high-fat diets in LDLR-/- mice.
    Yao J; Qin Z
    J Trace Elem Med Biol; 2015; 31():11-7. PubMed ID: 26004886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-4F alters hyperlipidemic (but not healthy) mouse plasma to reduce platelet aggregation.
    Buga GM; Navab M; Imaizumi S; Reddy ST; Yekta B; Hough G; Chanslor S; Anantharamaiah GM; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):283-9. PubMed ID: 19965777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo.
    Yang M; Kholmukhamedov A; Schulte ML; Cooley BC; Scoggins NO; Wood JP; Cameron SJ; Morrell CN; Jobe SM; Silverstein RL
    Blood Adv; 2018 Nov; 2(21):2848-2861. PubMed ID: 30381401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.
    Schneider JG; Zhu Y; Coleman T; Semenkovich CF
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2699-706. PubMed ID: 17951320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperlipidemia induces typical atherosclerosis development in Ldlr and Apoe deficient rats.
    Zhao Y; Yang Y; Xing R; Cui X; Xiao Y; Xie L; You P; Wang T; Zeng L; Peng W; Li D; Chen H; Liu M
    Atherosclerosis; 2018 Apr; 271():26-35. PubMed ID: 29459263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist-specific impairment of coronary vascular function in genetically altered, hyperlipidemic mice.
    Lamping KG; Nuno DW; Chappell DA; Faraci FM
    Am J Physiol; 1999 Apr; 276(4):R1023-9. PubMed ID: 10198381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
    Ravindran R; Krishnan LK
    Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia.
    Gallagher EJ; Zelenko Z; Neel BA; Antoniou IM; Rajan L; Kase N; LeRoith D
    Oncogene; 2017 Nov; 36(46):6462-6471. PubMed ID: 28759039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperlipidemia is a major determinant of neointimal formation in LDL receptor-deficient mice.
    Tian J; Pei H; Sanders JM; Angle JF; Sarembock IJ; Matsumoto AH; Helm GA; Shi W
    Biochem Biophys Res Commun; 2006 Jul; 345(3):1004-9. PubMed ID: 16712797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary diacylglycerol extenuates arterial thrombosis in apoE and LDLR deficient mice.
    Ijiri Y; Naemura A; Yamashita T; Meguro S; Watanabe H; Tokimitsu I; Yamamoto J
    Thromb Res; 2006; 117(4):411-7. PubMed ID: 15885757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions.
    Yang M; Cooley BC; Li W; Chen Y; Vasquez-Vivar J; Scoggins NO; Cameron SJ; Morrell CN; Silverstein RL
    Blood; 2017 May; 129(21):2917-2927. PubMed ID: 28336528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XI regulates pathological thrombus formation on acutely ruptured atherosclerotic plaques.
    van Montfoort ML; Kuijpers MJ; Knaup VL; Bhanot S; Monia BP; Roelofs JJ; Heemskerk JW; Meijers JC
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1668-73. PubMed ID: 24947525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Density Lipoprotein Receptor-Dependent and Low-Density Lipoprotein Receptor-Independent Mechanisms of Cyclosporin A-Induced Dyslipidemia.
    Kockx M; Glaros E; Leung B; Ng TW; Berbée JF; Deswaerte V; Nawara D; Quinn C; Rye KA; Jessup W; Rensen PC; Meikle PJ; Kritharides L
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1338-49. PubMed ID: 27150391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.